These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7534518)

  • 1. Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer.
    Rudan I; Skorić T; Rudan N
    Acta Med Croatica; 1994; 48(4-5):165-70. PubMed ID: 7534518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer prognosis. I. Prognostic factors in patients with node-negative (N0) breast cancer.
    Rudan I; Skorić T; Rudan N
    Acta Med Croatica; 1994; 48(4-5):159-63. PubMed ID: 7534517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer prognosis. III. Prognostic factors in patients with distant metastases (M1) at the time of diagnosis.
    Rudan I; Skorić T; Rudan N
    Acta Med Croatica; 1994; 48(4-5):171-4. PubMed ID: 7534519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between male and female breast cancer. III. Prognostic features.
    Rudan I; Rudan N; Basić N; Basić V; Rudan D; Jambrisak Z
    Acta Med Croatica; 1997; 51(3):135-41. PubMed ID: 9248110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of prognostic factors in breast cancer at University Hospital for Tumors].
    Lesar M; Stanec M; Oresić T
    Acta Med Croatica; 2006; 60(1):35-41. PubMed ID: 16802570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and prognosis in breast cancer patients over 70 years of age].
    Zhao WH; Xu BH; Li Q; Zhang P; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):385-8. PubMed ID: 17045008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
    Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
    Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland JM; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
    J Clin Oncol; 2003 Sep; 21(18):3469-78. PubMed ID: 12972522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma.
    Bièche I; Lazar V; Noguès C; Poynard T; Giovangrandi Y; Bellet D; Lidereau R; Vidaud M
    Clin Cancer Res; 1998 Mar; 4(3):671-6. PubMed ID: 9533536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
    Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.